Search Results

AT-406 (SM-406) 5mg  | 98%

APEXBIO TECHNOLOGY LLC

IAP inhibitor Apoptosis|IAP

More Information Supplier Page

×

AT-406 (SM-406)

AT-406 (SM-406) 10mM (in 1mL DMSO)  | 98%

APEXBIO TECHNOLOGY LLC

IAP inhibitor Apoptosis|IAP

More Information Supplier Page

×

AT-406 (SM-406)

Trametinib (GSK1120212) 500mg  | 99.01%

APEXBIO TECHNOLOGY LLC

MEK1 and MEK2 inhibitor, potent and selective MAPK Signaling|MEK1/2

More Information Supplier Page

×

Trametinib (GSK1120212)

Trametinib (GSK1120212) 200mg  | 99.01%

APEXBIO TECHNOLOGY LLC

MEK1 and MEK2 inhibitor, potent and selective MAPK Signaling|MEK1/2

More Information Supplier Page

×

Trametinib (GSK1120212)

Trametinib (GSK1120212) 50mg  | 99.01%

APEXBIO TECHNOLOGY LLC

MEK1 and MEK2 inhibitor, potent and selective MAPK Signaling|MEK1/2

More Information Supplier Page

×

Trametinib (GSK1120212)

Dasatinib (BMS-354825) 10mM (in 1mL DMSO)  | 98.09%

APEXBIO TECHNOLOGY LLC

Src and BCR-Abl inhibitor TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Dasatinib (BMS-354825)

Dasatinib (BMS-354825) 100mg  | 98.09%

APEXBIO TECHNOLOGY LLC

Src and BCR-Abl inhibitor TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Dasatinib (BMS-354825)

Dasatinib (BMS-354825) 500mg  | 98.09%

APEXBIO TECHNOLOGY LLC

Src and BCR-Abl inhibitor TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Dasatinib (BMS-354825)

Trametinib (GSK1120212) 10mM (in 1mL DMSO)  | 99.01%

APEXBIO TECHNOLOGY LLC

MEK1 and MEK2 inhibitor, potent and selective MAPK Signaling|MEK1/2

More Information Supplier Page

×

Trametinib (GSK1120212)

Trametinib (GSK1120212) Evaluation Sample  | 99.01%

APEXBIO TECHNOLOGY LLC

MEK1 and MEK2 inhibitor, potent and selective MAPK Signaling|MEK1/2

More Information Supplier Page

×

Trametinib (GSK1120212)